Stephen Willey

Q: What is Stephen Willey's success rate?

Stephen Willey currently has a success rate of 88.88426482447849.

Q: What is the average return of Stephen Willey's calls?

Their stock ratings have generated an average return of 34.35471236811205.

Stifel | Healthcare

Stephen Willey is an analyst from Stifel specializing in the Healthcare sector. Ranked #769 out of 4721 analysts, they have issued 22 stock ratings with a success rate of 88.88% and an average return of 34.35%.

Stephen Willey has a well-established track record, with 22 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.88% and an average return of 34.35%, underscoring their expertise and ability to identify winning opportunities for investors.

#769

Out of 4721

Total Ratings

+88.88%

Success Rate

+34.35%

Average Return

Recent Ratings Analysis

CADL

Buy

Jul 13, 2026

Target

$22.00

Current

$9.64

Performance

0.00%

Stephen Willey rated CADL as Buy on Jul 13, 2026, setting a price target of 22. Shares have remained stable near 9.64, leaving the 22 target still in play.

NRIX

Buy

Jul 10, 2026

Target

$40.00

Current

$22.71

Performance

-1.52%

On Jul 10, 2026, NRIX was given a Buy rating by Stephen Willey, with a target price of 40. The stock traded sideways with a -1.52% move, keeping the bullish thesis unresolved.

EXEL

Hold

May 06, 2026

Target

$47.00

Current

$56.04

Performance

15.07%

EXEL received a Hold rating from Stephen Willey on May 06, 2026, aiming for 47. Investors saw gains of 15.07% that the cautious stance didn’t fully capture.

INCY

Buy

Apr 29, 2026

Target

$123.00

Current

$114.23

Performance

15.27%

On Apr 29, 2026, Stephen Willey published a Buy outlook on INCY, with a target of 123. Shares gained 15.27%, underscoring the accuracy of the bullish outlook toward 123.

CELC

Buy

Mar 26, 2026

Target

$125.00

Current

$103.79

Performance

—

Stephen Willey on Mar 26, 2026 assigned CELC a Buy rating, with a price target of 125. The recommendation remains pending validation as shares consolidate around 103.79.

INSM

Buy

Mar 24, 2026

Target

$208.00

Current

$109.14

Performance

-21.56%

On Mar 24, 2026, Stephen Willey reaffirmed INSM with a Buy rating, targeting 208. Shares slid 21.56% despite the recommendation, highlighting downside risks.

ZYME

Buy

Mar 03, 2026

Target

$47.00

Current

$24.94

Performance

2.00%

ZYME was rated Buy by Stephen Willey on Mar 03, 2026, with a price objective of 47. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ACLX

Hold

Feb 24, 2026

Target

$127.00

Current

$115.07

Performance

1.16%

On Feb 24, 2026, Stephen Willey initiated coverage on ACLX with a Hold rating and target of 127. The stock’s lack of movement around 115.07 aligned with a cautious approach.

IRON

Buy

Feb 17, 2026

Target

$125.00

Current

$75.98

Performance

15.88%

Stephen Willey issued a Buy recommendation for IRON on Feb 17, 2026, price target set at 125. Investors following the Buy call captured upside momentum, with shares now at 75.98.

NKTX

Buy

Nov 11, 2025

Target

$11.00

Current

$2.79

Performance

38.81%

On Nov 11, 2025, NKTX was evaluated by Stephen Willey, who gave a Buy rating and target of 11. This case illustrates how a timely bullish rating can translate into tangible gains of 38.81%.

XFOR

Buy

Aug 29, 2025

Target

$9.00

Current

$4.05

Performance

7.71%

Stephen Willey rated XFOR as Buy on Aug 29, 2025, setting a price target of 9. The call has proven timely, with shares rising 7.71% toward the price target of 9.

ABCL

Buy

Aug 08, 2025

Target

$7.00

Current

$6.52

Performance

53.41%

On Aug 08, 2025, ABCL was given a Buy rating by Stephen Willey, with a target price of 7. The stock rallied 53.41% after the rating, narrowing the gap to the target of 7 and validating the bullish stance.

CBIO

Buy

Jun 25, 2025

Target

$28.00

Current

$15.69

Performance

-12.83%

CBIO received a Buy rating from Stephen Willey on Jun 25, 2025, aiming for 28. The rating hasn’t played out as hoped, with the stock trading 12.83% below expectations.

BOLT

Hold

Mar 25, 2025

Target

$1.25

Current

$3.78

Performance

800.00%

On Mar 25, 2025, Stephen Willey published a Hold outlook on BOLT, with a target of 1.25. The Hold call missed some of the bullish momentum as shares advanced toward 1.25.

VOR

Buy

Mar 21, 2025

Target

$5.00

Current

$18.03

Performance

3.62%

Stephen Willey on Mar 21, 2025 assigned VOR a Buy rating, with a price target of 5. The recommendation remains pending validation as shares consolidate around 18.03.

GERN

Buy

Feb 27, 2025

Target

$4.00

Current

$1.42

Performance

-18.39%

On Feb 27, 2025, Stephen Willey reaffirmed GERN with a Buy rating, targeting 4. Shares slid 18.39% despite the recommendation, highlighting downside risks.

IGMS

Hold

Jan 10, 2025

Target

$2.50

Current

$1.27

Performance

-39.23%

IGMS was rated Hold by Stephen Willey on Jan 10, 2025, with a price objective of 2.5. Investors who stayed cautious avoided some of the 39.23% decline.

BCAX

Buy

Oct 08, 2024

Target

$47.00

Current

$28.15

Performance

24.83%

On Oct 08, 2024, Stephen Willey initiated coverage on BCAX with a Buy rating and target of 47. The stock’s climb of 24.83% since the call highlights the foresight in the rating.

CUE

Buy

Aug 20, 2024

Target

$4.00

Current

$30.92

Performance

3478.70%

Stephen Willey issued a Buy recommendation for CUE on Aug 20, 2024, price target set at 4. Investors following the Buy call captured upside momentum, with shares now at 30.92.

HLVX

Hold

Jul 09, 2024

Target

$3.00

Current

$2.09

Performance

23.67%

On Jul 09, 2024, HLVX was evaluated by Stephen Willey, who gave a Hold rating and target of 3. Investors who stayed in despite the Hold saw upside of 23.67%.

MGNX

Hold

May 10, 2024

Target

$7.00

Current

$4.50

Performance

35.95%

Stephen Willey rated MGNX as Hold on May 10, 2024, setting a price target of 7. Despite the Hold call, shares climbed 35.95% to 4.5, revealing unexpected momentum.

Frequency Asked Questions

Who is Stephen Willey?

Stephen Willey is an analyst from Stifel specializing in the Healthcare sector.

What is Stephen Willey's success rate?

Stephen Willey currently has a success rate of +88.88%.

How many ratings has Stephen Willey issued?

Stephen Willey has issued 22 stock ratings so far.

What is the average return of Stephen Willey's calls?

Their stock ratings have generated an average return of +34.35%.

What is Stephen Willey's ranking?

Stephen Willey is ranked #769 out of 4721 analysts.

What types of ratings does Stephen Willey give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Stephen Willey?

You can follow Stephen Willey by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Stephen Willey?

Their latest rating was a Buy on CADL issued on 2026-07-13.